Bone growth stimulator market to reach $2.89 billion by 2030

The global bone growth stimulator market is expanding on rising fracture rates, broader use of non-surgical orthopedic care and new device features. The market is projected to grow from $1.8 billion in 2025 to $1.99 billion in 2026, with North America leading in 2025 and Asia-Pacific expected to grow fastest through 2030.

Why it matters: - Rising fracture incidence and more orthopedic procedures are increasing demand for devices that can support healing without surgery. - The market’s projected rise to $2.89 billion by 2030 signals continued spending on non-invasive and home-based bone repair therapies.

What happened: - The Business Research Company published a new bone growth stimulator market report covering market size, trends and global forecasts for 2026-2035. - The report estimates the market will grow from $1.8 billion in 2025 to $1.99 billion in 2026, a 10.4% CAGR. - The report forecasts the market will reach $2.89 billion by 2030, growing at a 9.8% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth in the coming years.

The details: - Bone growth stimulators are electrical devices used to help bones fuse and heal after fractures. - The devices use pulsed electromagnetic fields or ultrasound waves to deliver energy to the healing area. - The electromagnetic stimulation draws oppositely charged bone fragments together and supports new bone growth and fusion. - The technology is used for fractures or fusions that are difficult to heal. - Historic growth has been supported by more bone fractures, more spinal fusion surgeries, wider access to orthopedic treatment centers, growing use of non-surgical bone healing methods and easier access to external stimulation devices. - Future growth is expected to come from home-based orthopedic therapies, smart medical devices, broader outpatient orthopedic care, pressure to reduce surgical interventions and advances in bioelectrical stimulation. - Major trends include non-invasive bone growth stimulators, more ultrasound-based devices, smart monitoring features, home-use bone healing products and faster fracture recovery tools. - The report’s regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report also adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report is available as a free sample and the full report.

Between the lines: - The forecast suggests a shift from clinic-centered treatment toward at-home and outpatient recovery, where convenience and reduced procedure intensity matter more. - The emphasis on smart monitoring and ultrasound-based devices points to a market competing on usability and follow-up support, not just healing performance. - A June 2025 National Institutes of Health analysis cited via PubMed projected China’s age-standardized fracture rates for radius and/or ulna fractures to keep rising in both men and women, reinforcing the demand outlook.

What's next: - The market is likely to keep gaining from non-surgical care models and technologies that shorten recovery time. - Regional growth will hinge on how quickly Asia-Pacific expands access to orthopedic treatment and home-use healing devices. - The report’s forecast period extends through 2035, giving buyers and manufacturers a longer planning window around device adoption and product development.